Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > AACR

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Mar 30, 2022 4:36pm

76 Views

Post# 34560506

RE:RE:AACR

Paul is NOT an entrepreneur, he's a big pharma big spending big budget guy he's not good at promoting his company. He his a rooky in finance and totally relies on his lame CFO for the financings and even worse IR now. I heard that that Gary Littlejohn is actually helping us in keeping the big spender in check. The science team is the best part of the company but is learning the ropes and taking longer than i should, 14 months for a MTD. Also more patients in P1b should mean longer timeline too.. they never say those things, do they.

<< Previous

Bullboard Posts

Next >>

Increasing summer travel could see these airline stocks soar